| Lightcalls.com |
|
|
![]() |
Back in the 1950 researchers first ...Back in the 1950 researchers first realized that a high flush of cholesterol--found in fatty meats and other animal products--was a serious risk factor for heart disease. however recent findings suggest that it's more than just the fat in meat that's dangerous. Studies display that a high blood flat of a substance called homocysteine, which is synthesized from an amino acid establish in meat, dairy and provokes also raises the risk for heart disease significantly. More than a dozen studies have set up that people with even a moderately high progeny level of homocysteine are three times more likely to experience a heart attack or knock than those with low levels Seventeen studies are generally under way to determine whether reducing homocysteine actually defend s against heart disease, but the deductions won't be in for a small in number more years. Still, many doctors are already advising patients who are at risk to master their homocysteine level checked and to take grades to reduce it if it's equable moderately high. "I have patients who are teetering upon the edge of disease and don't have five years to wait for the outcomes of these studies," says William Castelli, MD former head of the ongoing Framingham Heart application of mind and now director of the Framingham Cardiovascular Institute in Massachusetts. While there are no put drugs intos that act on homocysteine directly, research definitively point outs that B vitamins--especially folic acid, [Bsub6] and [B.sub.12]--help retain homocysteine from building up in the vital fluid A study published in the August 22 edition of Circulation construct that participants who ate a diet rich in fruits and vegetables had higher flats of folic acid--and lower on a levels of homocysteine--than those who ate a typical, high-fat American diet lacking in adequate fruits and vegetables. the one and the other folic acid and [B.sub.6] are abundant in virid vegetables (like asparagus, broccoli, spinach and romaine lettuce) and in oranges, lentils and whole grains. unless for people who already have heart disease or who aren't able to significantly contract their homocysteine levels even after changing their diets, Castelli commits taking a daily B-100 mixed supplement--which contains 100 milligrams (mg) of riboflavin, niacin, and [Bsub6] 400 mg of folic acid and 100 micrograms of [Bsub12] A subject of attention published in the September issue of the Journal of the American corporation of Cardiology found that participants given 5 mg of folic acid by day were able to decrease their homocysteine levels by 11 percent That's a plenteous higher dose than most population should take, however. Says Bassam Nassar, MD PhD undivided of the lead authors of that close attention "Patients should follow the recommendations of their physicians regarding dosages. The flats of supplementation that need to be achieved vary from undivided patient to another." COPYRIGHT 2001 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |